Mixed Hormone Receptor (ER+/PR- Or ER-/PR+) Breast Cancer Prognosis

$ 20.50

5
(531)
In stock
Description

Detailed information on mixed hormone receptor (ER+/PR- or ER-/PR+) breast cancer prognosis, based on the latest scientific studies.

Neoadjuvant and hormonal therapy in Breast cancer - Yousef El

Mixed Hormone Receptor (ER+/PR- Or ER-/PR+) Breast Cancer

Outcome of breast cancer patients with low hormone receptor

Overall survival of patients stratified by estrogen receptor (ER

Frontiers Prognostic Relevance of Estrogen Receptor Status in

Hormone Receptor Status and Diagnosis in Breast Cancer

Imaging Test to Guide Breast Cancer Treatment - NCI

Triple Negative Breast Cancer—Review of Current and Emerging

Luminal breast cancer